LEGN
Legend Biotech Corp
$48.83
Earnings Summary
Revenue | $79.46Mn |
Net Profits | $-144.82Mn |
Net Profit Margins | -182.24% |
Highlights
Legend Biotech Corp’s revenue jumped 118.69% since last year same period to $79.46Mn in the Q4 2023. On a quarterly growth basis, Legend Biotech Corp has generated -17.24% fall in its revenue since last 3-months.
Legend Biotech Corp’s net profit fell -29.19% since last year same period to $-144.82Mn in the Q4 2023. On a quarterly growth basis, Legend Biotech Corp has generated -132.8% fall in its net profits since last 3-months.
Legend Biotech Corp’s net profit margin jumped 40.93% since last year same period to -182.24% in the Q4 2023. On a quarterly growth basis, Legend Biotech Corp has generated -181.28% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Legend Biotech Corp post its latest quarter earnings
EPS Estimate Current Quarter | -0.35 |
EPS Estimate Current Year | -0.35 |
Highlights
Legend Biotech Corp’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a 57.83% jump from last quarter’s estimates.
Legend Biotech Corp’s earning per share (EPS) estimates for the current year stand at -0.35.
Key Ratios
Key ratios of the Legend Biotech Corp post its Q4 2023 earnings
Earning Per Share (EPS) | -0.8 |
Highlights
Legend Biotech Corp’s earning per share (EPS) fell -29.03% since last year same period to -0.8 in the Q4 2023. This indicates that the Legend Biotech Corp has generated -29.03% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-03-11 | -0.83 | -0.8 | 3.61% |
2023-11-20 | -0.68 | -0.34 | 50% |
2023-08-15 | -0.6 | -1.14 | -90% |
2023-03-31 | -0.78 | -0.68 | 12.82% |
₹0 US Stocks a/c Opening Fee